journal article·2024-05Open access

Unveiling clinical applications of bacterial extracellular vesicles as natural nanomaterials in disease diagnosis and therapeutics

Chun Liu, Negar Yazdani, Corey S. Moran, Carlos Salomon, Chaminda Jayampath Seneviratne, Sašo Ivanovski, Pingping Han

Acta Biomaterialia· Volume 180

Abstract

Bacterial extracellular vesicles (BEVs) are naturally occurring bioactive membrane-bound nanoparticles released by both gram-negative and gram-positive bacterial species, exhibiting a multifaceted role in mediating host-microbe interactions across various physiological conditions. Increasing evidence supports BEVs as essential mediators of cell-to-cell communicaiton, influencing bacterial pathogenicity, disease mechanisms, and modulating the host immune response. However, the extent to which these BEV-mediated actions can be leveraged to predict disease onset, guide treatment strategies, and determine clinical outcomes remains uncertain, particularly in terms of their clinical translation potentials. This review briefly describes BEV biogenesis and their internalisation by recipient cells and summarises methods for isolation and characterization, essential for understanding their composition and cargo. Further, it discusses the potential of biofluid-associated BEVs as biomarkers for various diseases, spanning both cancer and non-cancerous conditions. Following this, we outline the ongoing human clinical trials of using BEVs for vaccine development. In addition to disease diagnostics, this review explores the emerging research of using natural or engineered BEVs as smart nanomaterials for applications in anti-cancer therapy and bone regeneration. This discussion extends to key factors for unlocking the clinical potential of BEVs, such as standardization of BEV isolation and characterisation, as well as other hurdles in translating these findings to the clinical setting. We propose that addressing these hurdles through collaborative research efforts and well-designed clinical trials holds the key to fully harnessing the clinical potential of BEVs. As this field advances, this review suggests that BEV-based nanomedicine has the potential to revolutionize disease management, paving the way for innovative diagnosis, therapeutics, and personalized medicine approaches. STATEMENT OF SIGNIFICANCE: Extracellular vesicles (EVs) from both host cells and bacteria serve as multifunctional biomaterials and are emerging in the fields of biomedicine, bioengineering, and biomaterials. However, the majority of current studies focus on host-derived EVs, leaving a gap in comprehensive research on bacteria-derived EVs (BEVs). Although BEVs offer an attractive option as nanomaterials for drug delivery systems, their unique nanostructure and easy-to-modify functions make them a potential method for disease diagnosis and treatment as well as vaccine development. Our work among the pioneering studies investigating the potential of BEVs as natural nanobiomaterials plays a crucial role in both understanding the development of diseases and therapeutic interventions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Bacterial Infections and Vaccines · Brucella: diagnosis, epidemiology, treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy10.1016/j.ccell.2018.03.015 ↗
2. Metagenomic analysis of the human distal gut microbiome10.1126/science.1124234 ↗
3. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans10.1016/j.cell.2016.01.013 ↗
4. Therapeutically harnessing extracellular vesicles10.1038/s41573-022-00410-w ↗
5. Composition and functions of bacterial membrane vesicles
6. Bacterial membrane vesicle functions, laboratory methods, and applications10.1016/j.biotechadv.2021.107869 ↗
7. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi10.1038/nrmicro3480 ↗
8. Types and origins of bacterial membrane vesicles10.1038/s41579-018-0112-2 ↗
9. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens10.1038/s41467-023-36101-2 ↗
10. Bacterial extracellular vesicle applications in cancer immunotherapy
11. Emerging role of bacterial extracellular vesicles in cancer10.1038/s41388-020-01509-3 ↗
12. The tremendous biomedical potential of bacterial extracellular vesicles10.1016/j.tibtech.2022.03.005 ↗
13. Systemically circulating bacterial extracellular vesicles: origin, fate, and function10.1016/j.tim.2021.12.012 ↗
14. Interactions between extracellular vesicles and microbiome in human diseases: new therapeutic opportunities10.1002/imt2.86 ↗
15. Biomaterial-based extracellular vesicle delivery for therapeutic applications10.1016/j.actbio.2021.01.010 ↗
16. Drug delivery with extracellular vesicles: from imagination to innovation10.1021/acs.accounts.9b00109 ↗
17. Bacterial membrane vesicles as smart drug delivery and carrier systems: a new nanosystems tool for current anticancer and antimicrobial therapy10.3390/pharmaceutics15041052 ↗
18. Helicobacter pylori-derived extracellular vesicles increased in the gastric juices of gastric adenocarcinoma patients and induced inflammation mainly via specific targeting of gastric epithelial cells10.1038/emm.2017.47 ↗
19. Blood-borne extracellular vesicles of bacteria and intestinal cells in patients with psychotic disorders
20. Bacterial extracellular vesicle composition in human urine and the 10-year risk of abdominal obesity10.1089/met.2022.0109 ↗
21. Analysis of the gut microbiome using extracellular vesicles in the urine of patients with colorectal cancer10.3904/kjim.2022.112 ↗
22. Microbiome profiling of nasal extracellular vesicles in patients with allergic rhinitis10.1016/j.waojou.2022.100674 ↗
23. Contamination of bacterial extracellular vesicles (bEVs) in human urinary extracellular vesicles (uEVs) samples and their effects on uEVs study10.1002/jex2.69 ↗
24. Bacteria-derived extracellular vesicles in urine as a novel biomarker for gastric cancer: integration of liquid biopsy and metagenome analysis10.3390/cancers13184687 ↗
25. Analysis of the human breast milk microbiome and bacterial extracellular vesicles in healthy mothers10.1038/s12276-020-0470-5 ↗
26. Metagenomic analysis of serum microbe-derived extracellular vesicles and diagnostic models to differentiate ovarian cancer and benign ovarian tumor10.3390/cancers12051309 ↗
27. Diagnostic models for atopic dermatitis based on serum microbial extracellular vesicle metagenomic analysis: a pilot study10.4168/aair.2020.12.5.792 ↗
28. Urine bacteria-derived extracellular vesicles and allergic airway diseases in children10.1159/000492677 ↗
29. Rapid assessment of microbiota changes in individuals with autism spectrum disorder using bacteria-derived membrane vesicles in urine10.5607/en.2017.26.5.307 ↗
30. 16S rRNA gene-based metagenomic analysis reveals differences in bacteria-derived extracellular vesicles in the urine of pregnant and non-pregnant women10.1038/emm.2015.110 ↗
31. Single-particle analysis of circulating bacterial extracellular vesicles reveals their biogenesis, changes in blood and links to intestinal barrier10.1002/jev2.12395 ↗
32. Salivary outer membrane vesicles and DNA methylation of small extracellular vesicles as biomarkers for periodontal status: a pilot study10.3390/ijms22052423 ↗
33. Mass-produced gram-negative bacterial outer membrane vesicles activate cancer antigen-specific stem-like CD8+ T cells which enables an effective combination immunotherapy with anti-PD-110.1002/jev2.12357 ↗
34. Combining augmented radiotherapy and immunotherapy through a nano-gold and bacterial outer-membrane vesicle complex for the treatment of glioblastoma10.3390/nano11071661 ↗
35. Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy10.1002/jev2.12120 ↗
36. Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL–programmed therapy against melanoma10.1126/sciadv.aba2735 ↗
37. Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer10.1016/j.apsb.2020.02.002 ↗
38. The inhibitory impacts of Lactobacillus rhamnosus GG-derived extracellular vesicles on the growth of hepatic cancer cells10.1016/j.micpath.2017.06.016 ↗
39. Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response10.1038/s41467-017-00729-8 ↗
40. Bone-targeted engineered bacterial extracellular vesicles delivering miRNA to treat osteoporosis10.1016/j.compositesb.2023.111047 ↗
41. Proteus mirabilis vesicles induce mitochondrial apoptosis by regulating miR96-5p/abca1 to inhibit osteoclastogenesis and bone loss
42. Extracellular vesicles from child gut microbiota enter into bone to preserve bone mass and strength10.1002/advs.202004831 ↗
43. Extracellular vesicles derived from Akkermansia muciniphila promote placentation and mitigate preeclampsia in a mouse model10.1002/jev2.12328 ↗
44. Saliva biofilm-derived outer membrane vesicles regulate biofilm formation and immune response of oral epithelial cells on titanium surfaces10.1007/s00784-023-05454-9 ↗
45. Extracellular vesicles from gram-positive and gram-negative probiotics remediate stress-induced depressive behavior in mice10.1007/s12035-021-02655-9 ↗
46. Immunoregulatory effects of Lactococcus lactis-derived extracellular vesicles in allergic asthma10.1002/clt2.12138 ↗
47. Kim · 2015 · 97
48. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions10.1038/nrmicro3525 ↗
49. Bacterial outer membrane vesicles as a platform for biomedical applications: an update10.1016/j.jconrel.2020.04.031 ↗
50. Outer membrane vesicle production by Escherichia coli is independent of membrane instability10.1128/JB.00498-06 ↗
51. Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response10.1016/j.micinf.2006.05.001 ↗
52. Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate10.1111/j.1574-6968.2009.01669.x ↗
53. Biological functions and biogenesis of secreted bacterial outer membrane vesicles10.1146/annurev.micro.091208.073413 ↗
54. Outer membrane vesicles (OMVs) of gram-negative bacteria: a perspective update10.3389/fmicb.2017.01053 ↗
55. Outer membrane vesicles: biogenesis, functions, and issues10.1128/mmbr.00032-22 ↗
56. Outer membrane vesicles of Gram-negative bacteria: an outlook on biogenesis10.3389/fmicb.2021.557902 ↗
57. Bacterial membrane vesicles: biogenesis, immune regulation and pathogenesis10.1111/cmi.12658 ↗
58. An ABC transport system that maintains lipid asymmetry in the gram-negative outer membrane10.1073/pnas.0903229106 ↗
59. Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: advances and perspectives
60. New type of outer membrane vesicle produced by the Gram-negative bacterium Shewanella vesiculosa M7T: implications for DNA content10.1128/AEM.03657-12 ↗
61. Extracellular vesicles: an emerging platform in gram-positive bacteria10.15698/mic2020.12.737 ↗
62. Gram-positive bacterial extracellular vesicles and their impact on health and disease10.3389/fmicb.2018.01502 ↗
63. Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation10.1111/j.1398-9995.2010.02483.x ↗
64. Extracellular vesicles derived from the periodontal pathogen Filifactor alocis induce systemic bone loss through Toll-like receptor 210.1002/jev2.12157 ↗
65. Engineered extracellular vesicles for cancer therapy10.1002/adma.202005709 ↗
66. The role of bacterial outer membrane vesicles for intra-and interspecies delivery10.1111/1462-2920.12048 ↗
67. Bacterial extracellular vesicles-based therapeutic strategies for bone and soft tissue tumors therapy10.7150/thno.78034 ↗
68. Microbiota-derived extracellular vesicles in interkingdom communication in the gut10.1002/jev2.12161 ↗
69. Mechanisms of outer membrane vesicle entry into host cells10.1111/cmi.12655 ↗
70. Bacterial outer membrane vesicles in trafficking, communication and the host-pathogen interaction10.1159/000346770 ↗
71. Bacteriolytic effect of membrane vesicles from Pseudomonas aeruginosa on other bacteria including pathogens: conceptually new antibiotics10.1128/jb.178.10.2767-2774.1996 ↗
72. Perinuclear localization of internalized outer membrane vesicles carrying active cytolethal distending toxin from Aggregatibacter actinomycetemcomitans10.1128/IAI.06069-11 ↗
73. Outer membrane vesicles as platform vaccine technology10.1002/biot.201400395 ↗
74. Microbiota–host communications: bacterial extracellular vesicles as a common language10.1371/journal.ppat.1009508 ↗
75. Microbiota-derived extracellular vesicles in interkingdom communication in the gut10.1002/jev2.12161 ↗
76. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation10.1177/1756283X12459294 ↗
77. Emerging role of bacterial outer membrane vesicle in gastrointestinal tract10.1186/s13099-023-00543-2 ↗
78. The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients10.1038/emm.2017.7 ↗
79. Bacterial extracellular vesicles: an emerging avenue to tackle diseases10.1016/j.tim.2023.05.010 ↗
80. Skin-targeted delivery of extracellular vesicle-encapsulated curcumin using dissolvable microneedle arrays10.1016/j.actbio.2022.06.046 ↗
81. Extracellular vesicle-based therapeutics for the regeneration of chronic wounds: current knowledge and future perspectives10.1016/j.actbio.2020.11.001 ↗
82. The relationship between biofilm and outer membrane vesicles: a novel therapy overview10.1093/femsle/fnv117 ↗
83. Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264. 7 macrophages10.1186/s12866-020-01953-x ↗
84. The role of bacterial membrane vesicles in antibiotic resistance10.1111/nyas.14932 ↗
85. Immune modulation by bacterial outer membrane vesicles10.1038/nri3837 ↗
86. Human lung tissue explants reveal novel interactions during Legionella pneumophila infections10.1128/IAI.00703-13 ↗
87. The membrane expression of Neisseria meningitidis adhesin A (NadA) increases the proimmune effects of MenB OMVs on human macrophages, compared with NadA–OMVs, without further stimulating their proinflammatory activity on circulating monocytes10.1189/jlb.0109030 ↗
88. Helicobacter pylori membrane vesicles stimulate innate pro-and anti-inflammatory responses and induce apoptosis in Jurkat T cells10.1128/IAI.01443-13 ↗
89. Orchestration of human macrophage NLRP3 inflammasome activation by Staphylococcus aureus extracellular vesicles10.1073/pnas.1915829117 ↗
90. Proteome and immune responses of extracellular vesicles derived from macrophages infected with the periodontal pathogen Tannerella forsythia10.1002/jev2.12381 ↗
91. Activation of immune and defense responses in the intestinal mucosa by outer membrane vesicles of commensal and probiotic Escherichia coli strains
92. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines10.1080/20013078.2018.1535750 ↗
93. A magnetic bead-mediated selective adsorption strategy for extracellular vesicle separation and purification10.1016/j.actbio.2021.02.004 ↗
94. Quantitative proteomic analysis of extracellular vesicle subgroups isolated by an optimized method combining polymer-based precipitation and size exclusion chromatography10.1002/jev2.12087 ↗
95. Enrichment of calcifying extracellular vesicles using density-based ultracentrifugation protocol10.3402/jev.v3.25129 ↗
96. Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria10.1016/j.micres.2014.09.006 ↗
97. Size exclusion chromatography to analyze bacterial outer membrane vesicle heterogeneity
98. Isolation of extracellular vesicles: general methodologies and latest trends10.1155/2018/8545347 ↗
99. Microfluidic systems in extracellular vesicles single analysis. A systematic review10.1016/j.trac.2023.116920 ↗
100. Outer membrane vesicle induction and isolation for vaccine development10.3389/fmicb.2021.629090 ↗